Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Belantamab Mafodotin for Multiple Myeloma
Recruiting1 awardPhase 2
Montreal, Quebec
This trial will test different ways of giving the drug belantamab mafodotin to people with a certain kind of blood cancer to see if it can be more effective with fewer side effects.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.